Creative Biolabs-Immuno-oncology

Anti-FGFR2 (clone Atto-MuIO-0Z1G) SynExpress SV-BF-L/T-E Modified CD8+ T cells (CAT#: ITS-1224-CR708)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FGFR2 (clone Atto-MuIO-0Z1G). We employs the Adenovirus (SV40-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Single base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
FGFR2
Clone
Atto-MuIO-0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SV40
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
Adenovirus
Transformation Accuracy
0.93
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.